Skip to content

Efficacy of INTORUS as a Therapeutic Tool in Motor Intervention in Patients at Aspace Centres in the Province of Cáceres

Efficacy of the INTORUS Device as a Therapeutic Tool in Motor Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05753800
Enrollment
50
Registered
2023-03-03
Start date
2023-01-01
Completion date
2023-08-31
Last updated
2023-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Motor Activity, Motor Disorders

Keywords

cerebral palsy, motor activity, motor disorders

Brief summary

The goal of this Clinical Trial is to verify the effectiveness of the use of the Intorus device in the motor intervention in patients with cerebral palsy and related syndromes. The main question it aims to answer is: Does the use of the Intorus tool manage to improve the mobility of upper limbs (MMSS) in patients with infantile cerebral palsy to increase their performance in activities of daily living? A total of approximately 50 users will participate in the study. Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the motor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the motor level with the INTORUS device. Randomization will be carried out using the Oxford Minimization and Randomization software.

Detailed description

The intervention program will take place during the Occupational Therapy sessions and will be carried out by the center's occupational therapists. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the patient attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs. Each session will consist of several exercises with their corresponding rest breaks. EVALUATION The evaluations will be carried out prior to the start of treatment, at 20 weeks of treatment and at 40 weeks of treatment once the intervention program has concluded. The tools used to carry out the evaluation will be: * Questionnaire of sociodemographic variables * Goniometric * Shoulder joint: abduction-adduction, flexion-extension, external-internal rotation. * Elbow joint: flexion-extension, pronation-supination. * Wrist joint: flexion-extension, radial-ulnar deviation. * Articulation of the thumb: abduction-adduction, flexion-extension, opposition. * Articulation of the fingers: flexion-extension, abduction-adduction. * Gross Motor Function Classification * Assessment of a functional gesture * Satisfaction questionnaire for professionals The evaluations will be carried out by a professional external to the center to avoid bias. Once the intervention period is over, a questionnaire will be passed to the professionals participating in the study to assess the usefulness of the device, the degree of satisfaction with it and the usefulness of the therapies applied. TIMELINE The intervention consists of 40 treatment sessions lasting 45 minutes each with a frequency of 2 days a week in which the intervention program described above will be developed. Previously, the participants will receive a session 0 in which they will carry out a first contact with the device.

Interventions

DEVICEINTORUS

Motor intervention protocol with Intorus consisting of a series of exercises of progressive difficulty

Sponsors

University of Extremadura
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Users with infantile cerebral palsy and/or related syndromes. * Ages between 4 and 18 years. * Motor disability. * Affectation in the mobility of upper limbs. * Informed consent signed by parents/guardians.

Exclusion criteria

* Patients with another type of pathology not related to cerebral palsy. * Under 4 years and over 18 years. * Participants who do not meet the inclusion criteria described above

Design outcomes

Primary

MeasureTime frameDescription
IMPROVEMENT OF UPPER LIMB MOBILITY AS MEASURED BY GONIOMETERBefore starting treatment. After 20 weeks of treatment and at the end of treatment (40 weeks).Measuring joint amplitude of upper limb joints with goniometer

Secondary

MeasureTime frameDescription
Functional Gesture of Activities of Daily LivingBefore starting treatment. After 20 weeks of treatment and at the end of treatment (40 weeks).Measurement of the performance of a functional gesture performed in the patient's activities of daily living.

Other

MeasureTime frameDescription
Participants satisfaction questionnaireThrough study completion, an average of 6 monthsMeasurement of participants' satisfaction with the use of the tool measured with a questionnaire designed by us.
Professional satisfaction questionnaireThrough study completion, an average of 6 monthsMeasurement of professionals' satisfaction with the use of the tool measured with a questionnaire designed by ourselves.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026